Moreover, mice mutated on tp53, expressing homozygous HSF1 (HSF1+/+), developed sarcomas in 70% of cases, compared to tp53 mutated mice with mono-allelic HSF1 invalidation (+/−) that develop sarcomas in only 30% of cases [163]. Here, HSF1 is linked to sarcoma.